0
2022
Medical Device Regulatory Affairs Market

Medical Device Regulatory Affairs Market

by Services (Regulatory consulting /Strategic Services, Regulatory writing and publishing, Legal representation, Product Registration and Clinical trials, Others), by Service Provider (In-House, Out sourcing), by Types (Diagnostic, Therapeutics), by Indication (Infectious Diseases, Oncology and Hematology, Gynaecology and Obstetrics, Muscusloskeletal Disorders, Respiratory, Cardiovascular, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A16307
May 2022 | Pages: 356
Tables: 188
Charts: 68
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Medical Device Regulatory Affairs Market Research, 2031

The global medical device regulatory affairs market size was valued at $7.0 billion in 2021, and is projected to reach $12.2 billion by 2031, growing at a CAGR of 5.8% from 2022 to 2031. Medical device regulatory affair is a government affair, which is a specialty in regulated industries such as pharmaceuticals, medical devices, and agrochemicals. Within the healthcare industry, regulatory affairs have a very specific connotation.

Impact of COVID-19 pandemic is expected to remain negative for the medical device regulatory affairs market. As the COVID-19 pandemic continues to unfold, medical device companies find it difficult to make informed decisions about their products, supply chains, and regulatory obligations in the midst of uncertainty.

Medical Device Regulatory Affairs Market, Medical Device Regulatory Affairs Market Size, Medical Device Regulatory Affairs Market Share, Medical Device Regulatory Affairs Market Analysis, Medical Device Regulatory Affairs Market Growth, Medical Device Regulatory Affairs Market Opportunity, Medical Device Regulatory Affairs Market Trends, Medical Device Regulatory Affairs Market Forecast

The regulatory function in the healthcare industry is critical in ensuring the availability of safe and effective healthcare products around the world. Regulatory professionals include individuals who ensure regulatory compliance and prepare submissions, as well as those whose primary job function is clinical affairs or quality assurance. Medical device regulatory affairs experts serve as a link between the medical device industry and regulatory bodies around the world, including the United States Food and Drug Administration (USFDA), Medicines and Healthcare Products Regulatory Agency (MHRA) for UK, European Medicine Agency for the European Union, Central Drugs Standard Control Organization (CDSCO) for India, Pharmaceutical & Food Safety Bureau (PFSB) for Japan, and Therapeutic Good Administration (TGA) for Australia.

A novel medical device might cost millions to develop, and any error has a significant influence on the company's reputation. As medical devices play such an important role in people's lives, it will help in diagnosis, prevention and treatment of various diseases so it is important to check the quality of the product/medical devices and for this purpose the regulatory affairs expert is fully responsible for keeping products in conformity and keeping track of all paperwork. One of the most important responsibilities of the regulatory specialist is to guarantee that all information about device is accurately communicated to patients. Even a minor blunder in any regulatory activity can result in the product being recalled, as well as loss of millions of dollars.

The market is expected to witness a moderate growth during the forecast period, owing to rise in adoption and development of advanced medical devices for the treatment of various diseases such as cardiovascular, cancer, and other infectious diseases, along with various technological advancements and their increased applications in the healthcare sector. Furthermore, surge in geriatric population along with various technological advancements in the market to meet the unmet needs of patients provides significant opportunities for existing players and new entrants.

However, factors such as high cost of providing regulatory services and increase in number of cyberattacks for software based medical devices are expected to hamper growth of the market up to some extent during the forecast period.

The medical device regulatory affairs market size is segmented into Services, Service Provider, Types and Indication. On the basis of services, the market is divided into regulatory consulting /strategic services, regulatory writing & publishing, legal representation, product registration & clinical trials, and others. By service provider, it is classified into in-house and outsourcing. The type segment includes diagnostics and therapeutics. Depending on indication, the market is fragmented into infectious diseases, oncology & hematology, gynecology & obstetric, musculoskeletal disorder, respiratory, cardiovascular and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Services Segment review

Medical Device Regulatory Affairs Market

By services segment, the medical device regulatory affairs market is divided into regulatory consulting /strategic services, regulatory writing & publishing, legal representation, product registration & clinical trials, and others. The legal representation segment was the highest revenue contributor to the market, in 2021, and is estimated to register a CAGR of 6.1%. Owing to increase in demand for traditional and special 510(k), pre-market approval (PMA) preparation & submission, design dossier preparation & FDA notified body, and ISO 13485 registrar audit preparation & participation accessibility are expected to drive the market growth.

The product registration and clinical trials segment is estimated to reach at a significant CAGR of 6.8% during the medical device regulatory affairs market forecast period. Owing to rising demand for faster approval processes.

Service Provider Segment Review

Medical Device Regulatory Affairs Market

By service provider, the outsourcing segment was the highest revenue contributor to the market and is estimated to register a CAGR of 6.0%. The increase in number of clinical studies conducted and providing regulatory guidance for the approval of medical device to the small-scale industries act as a driver to boost the growth of the market.

The in-house segment is estimated to reach at a significant CAGR of 5.5% during the forecast period. Owing to the increasing complexity of medical devices and increase in demand for regulatory services required by small scale industries to get their product approval globally also because of the advantages such as cost and time saving.

Types Segment Review

Medical Device Regulatory Affairs Market

By type, the therapeutics segment was the highest revenue contributor to the medical device regulatory affairs industry with a CAGR of 5.6%. Owing to increase in prevalence of various chronic diseases such as cancer, diabetes, cardiovascular diseases, and respiratory disorders that create demand for advanced therapeutic products.

For instance, increasing demand for technologically advanced products such as auto-injectors or pen needles for effective and efficient delivery of insulin in diabetic patients is driving the segment.

The diagnostic segment is estimated to reach a significant CAGR of 6.2% during the forecast period.  Due to a lack of supply, temporary approvals for expired therapeutic equipment such as respirators/ventilators and certification of similar equipment such as positive pressure breathing devices and anesthesia gas machines are permitted.

Indication Segment Review

Medical Device Regulatory Affairs Market

On the basis of indication, the musculoskeletal disorders segment was the highest revenue contributor to the market, with a CAGR of 4.6%. Due to increase in demand of advanced medical devices for oncology & hematology, the demand for the regulatory service required also increases which drives the growth of the market.

The cardiovascular segment is estimated to a significant CAGR of 6.5% during the forecast period. Owing to rise in prevalence of heart related disease which increase the demand of regulatory services for the approval of new medical devices.

Region Segment Review

Medical Device Regulatory Affairs Market

Region wise, the medical device regulatory affairs market share is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the largest shareholder in the medical device regulatory affairs market in 2021. Increase in geriatric population, R&D investments, and supportive government initiatives directed toward use of advanced medical devices for chronic diseases are the major factors that drive growth of the medical device regulatory affairs market.

Asia-Pacific medical device regulatory affairs market analysis is estimated to grow during the forecast period. Rise in number of product approval, increase in number of clinical trials procedures, surge in demand for regulatory services emphasis of prominent players in enhancing their presence and high demand for advanced medical devices in the region.

Key players operating in the global medical device regulatory affairs industry include Amerisource Bergen, Charles River, Cliniexpert, Emergo, Icbio, Icon PLC, IQVIA, NKG, Parexel and Pepgra.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical device regulatory affairs market analysis from 2021 to 2031 to identify the prevailing medical device regulatory affairs market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the medical device regulatory affairs market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical device regulatory affairs market trends, key players, market segments, application areas, and medical device regulatory affairs market growth strategies.

Medical Device Regulatory Affairs Market Report Highlights

Aspects Details
By Services
  • Regulatory consulting /Strategic Services
  • Regulatory writing and publishing
  • Legal representation
  • Product Registration and Clinical trials
  • Others
By Service Provider
  • In-House
  • Out sourcing
By Type
  • Diagnostic
  • Therapeutics
By Indication
  • Infectious Diseases
  • Oncology and Hematology
  • Gynaecology and Obstetrics
  • Muscusloskeletal Disorders
  • Respiratory
  • Cardiovascular
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, South Korea, Malaysia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Israel, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players parexel, NKG, Amerisource Bergen, Clini expert, Emergo, icon plc, IQVIA Holdings Inc., icbio cro, Pepgra, Charles river
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Regulatory consulting /Strategic Services

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Regulatory writing and publishing

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Legal representation

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Product Registration and Clinical trials

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

    • 4.6 Others

      • 4.6.1 Key market trends, growth factors and opportunities

      • 4.6.2 Market size and forecast, by region

      • 4.6.3 Market analysis by country

  • CHAPTER 5: MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 In-House

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Out sourcing

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

  • CHAPTER 6: MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 Diagnostic

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market analysis by country

    • 6.3 Therapeutics

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market analysis by country

  • CHAPTER 7: MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2 Infectious Diseases

      • 7.2.1 Key market trends, growth factors and opportunities

      • 7.2.2 Market size and forecast, by region

      • 7.2.3 Market analysis by country

    • 7.3 Oncology and Hematology

      • 7.3.1 Key market trends, growth factors and opportunities

      • 7.3.2 Market size and forecast, by region

      • 7.3.3 Market analysis by country

    • 7.4 Gynaecology and Obstetrics

      • 7.4.1 Key market trends, growth factors and opportunities

      • 7.4.2 Market size and forecast, by region

      • 7.4.3 Market analysis by country

    • 7.5 Muscusloskeletal Disorders

      • 7.5.1 Key market trends, growth factors and opportunities

      • 7.5.2 Market size and forecast, by region

      • 7.5.3 Market analysis by country

    • 7.6 Respiratory

      • 7.6.1 Key market trends, growth factors and opportunities

      • 7.6.2 Market size and forecast, by region

      • 7.6.3 Market analysis by country

    • 7.7 Cardiovascular

      • 7.7.1 Key market trends, growth factors and opportunities

      • 7.7.2 Market size and forecast, by region

      • 7.7.3 Market analysis by country

    • 7.8 Others

      • 7.8.1 Key market trends, growth factors and opportunities

      • 7.8.2 Market size and forecast, by region

      • 7.8.3 Market analysis by country

  • CHAPTER 8: MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY REGION

    • 8.1 Overview

      • 8.1.1 Market size and forecast

    • 8.2 North America

      • 8.2.1 Key trends and opportunities

      • 8.2.2 North America Market size and forecast, by Services

      • 8.2.3 North America Market size and forecast, by Service Provider

      • 8.2.4 North America Market size and forecast, by Types

      • 8.2.5 North America Market size and forecast, by Indication

      • 8.2.6 North America Market size and forecast, by country

        • 8.2.6.1 U.S.
          • 8.2.6.1.1 Market size and forecast, by Services
          • 8.2.6.1.2 Market size and forecast, by Service Provider
          • 8.2.6.1.3 Market size and forecast, by Types
          • 8.2.6.1.4 Market size and forecast, by Indication
        • 8.2.6.2 Canada
          • 8.2.6.2.1 Market size and forecast, by Services
          • 8.2.6.2.2 Market size and forecast, by Service Provider
          • 8.2.6.2.3 Market size and forecast, by Types
          • 8.2.6.2.4 Market size and forecast, by Indication
        • 8.2.6.3 Mexico
          • 8.2.6.3.1 Market size and forecast, by Services
          • 8.2.6.3.2 Market size and forecast, by Service Provider
          • 8.2.6.3.3 Market size and forecast, by Types
          • 8.2.6.3.4 Market size and forecast, by Indication
    • 8.3 Europe

      • 8.3.1 Key trends and opportunities

      • 8.3.2 Europe Market size and forecast, by Services

      • 8.3.3 Europe Market size and forecast, by Service Provider

      • 8.3.4 Europe Market size and forecast, by Types

      • 8.3.5 Europe Market size and forecast, by Indication

      • 8.3.6 Europe Market size and forecast, by country

        • 8.3.6.1 Germany
          • 8.3.6.1.1 Market size and forecast, by Services
          • 8.3.6.1.2 Market size and forecast, by Service Provider
          • 8.3.6.1.3 Market size and forecast, by Types
          • 8.3.6.1.4 Market size and forecast, by Indication
        • 8.3.6.2 France
          • 8.3.6.2.1 Market size and forecast, by Services
          • 8.3.6.2.2 Market size and forecast, by Service Provider
          • 8.3.6.2.3 Market size and forecast, by Types
          • 8.3.6.2.4 Market size and forecast, by Indication
        • 8.3.6.3 United Kingdom
          • 8.3.6.3.1 Market size and forecast, by Services
          • 8.3.6.3.2 Market size and forecast, by Service Provider
          • 8.3.6.3.3 Market size and forecast, by Types
          • 8.3.6.3.4 Market size and forecast, by Indication
        • 8.3.6.4 Italy
          • 8.3.6.4.1 Market size and forecast, by Services
          • 8.3.6.4.2 Market size and forecast, by Service Provider
          • 8.3.6.4.3 Market size and forecast, by Types
          • 8.3.6.4.4 Market size and forecast, by Indication
        • 8.3.6.5 Spain
          • 8.3.6.5.1 Market size and forecast, by Services
          • 8.3.6.5.2 Market size and forecast, by Service Provider
          • 8.3.6.5.3 Market size and forecast, by Types
          • 8.3.6.5.4 Market size and forecast, by Indication
        • 8.3.6.6 Rest of Europe
          • 8.3.6.6.1 Market size and forecast, by Services
          • 8.3.6.6.2 Market size and forecast, by Service Provider
          • 8.3.6.6.3 Market size and forecast, by Types
          • 8.3.6.6.4 Market size and forecast, by Indication
    • 8.4 Asia-Pacific

      • 8.4.1 Key trends and opportunities

      • 8.4.2 Asia-Pacific Market size and forecast, by Services

      • 8.4.3 Asia-Pacific Market size and forecast, by Service Provider

      • 8.4.4 Asia-Pacific Market size and forecast, by Types

      • 8.4.5 Asia-Pacific Market size and forecast, by Indication

      • 8.4.6 Asia-Pacific Market size and forecast, by country

        • 8.4.6.1 Japan
          • 8.4.6.1.1 Market size and forecast, by Services
          • 8.4.6.1.2 Market size and forecast, by Service Provider
          • 8.4.6.1.3 Market size and forecast, by Types
          • 8.4.6.1.4 Market size and forecast, by Indication
        • 8.4.6.2 China
          • 8.4.6.2.1 Market size and forecast, by Services
          • 8.4.6.2.2 Market size and forecast, by Service Provider
          • 8.4.6.2.3 Market size and forecast, by Types
          • 8.4.6.2.4 Market size and forecast, by Indication
        • 8.4.6.3 India
          • 8.4.6.3.1 Market size and forecast, by Services
          • 8.4.6.3.2 Market size and forecast, by Service Provider
          • 8.4.6.3.3 Market size and forecast, by Types
          • 8.4.6.3.4 Market size and forecast, by Indication
        • 8.4.6.4 South Korea
          • 8.4.6.4.1 Market size and forecast, by Services
          • 8.4.6.4.2 Market size and forecast, by Service Provider
          • 8.4.6.4.3 Market size and forecast, by Types
          • 8.4.6.4.4 Market size and forecast, by Indication
        • 8.4.6.5 Malaysia
          • 8.4.6.5.1 Market size and forecast, by Services
          • 8.4.6.5.2 Market size and forecast, by Service Provider
          • 8.4.6.5.3 Market size and forecast, by Types
          • 8.4.6.5.4 Market size and forecast, by Indication
        • 8.4.6.6 Rest of Asia-Pacific
          • 8.4.6.6.1 Market size and forecast, by Services
          • 8.4.6.6.2 Market size and forecast, by Service Provider
          • 8.4.6.6.3 Market size and forecast, by Types
          • 8.4.6.6.4 Market size and forecast, by Indication
    • 8.5 LAMEA

      • 8.5.1 Key trends and opportunities

      • 8.5.2 LAMEA Market size and forecast, by Services

      • 8.5.3 LAMEA Market size and forecast, by Service Provider

      • 8.5.4 LAMEA Market size and forecast, by Types

      • 8.5.5 LAMEA Market size and forecast, by Indication

      • 8.5.6 LAMEA Market size and forecast, by country

        • 8.5.6.1 Brazil
          • 8.5.6.1.1 Market size and forecast, by Services
          • 8.5.6.1.2 Market size and forecast, by Service Provider
          • 8.5.6.1.3 Market size and forecast, by Types
          • 8.5.6.1.4 Market size and forecast, by Indication
        • 8.5.6.2 Israel
          • 8.5.6.2.1 Market size and forecast, by Services
          • 8.5.6.2.2 Market size and forecast, by Service Provider
          • 8.5.6.2.3 Market size and forecast, by Types
          • 8.5.6.2.4 Market size and forecast, by Indication
        • 8.5.6.3 Saudi Arabia
          • 8.5.6.3.1 Market size and forecast, by Services
          • 8.5.6.3.2 Market size and forecast, by Service Provider
          • 8.5.6.3.3 Market size and forecast, by Types
          • 8.5.6.3.4 Market size and forecast, by Indication
        • 8.5.6.4 South Africa
          • 8.5.6.4.1 Market size and forecast, by Services
          • 8.5.6.4.2 Market size and forecast, by Service Provider
          • 8.5.6.4.3 Market size and forecast, by Types
          • 8.5.6.4.4 Market size and forecast, by Indication
        • 8.5.6.5 Rest of LAMEA
          • 8.5.6.5.1 Market size and forecast, by Services
          • 8.5.6.5.2 Market size and forecast, by Service Provider
          • 8.5.6.5.3 Market size and forecast, by Types
          • 8.5.6.5.4 Market size and forecast, by Indication
  • CHAPTER 9: COMPANY LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top winning strategies

    • 9.3. Product Mapping of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Key developments

  • CHAPTER 10: COMPANY PROFILES

    • 10.1 Amerisource Bergen

      • 10.1.1 Company overview

      • 10.1.2 Company snapshot

      • 10.1.3 Operating business segments

      • 10.1.4 Product portfolio

      • 10.1.5 Business performance

      • 10.1.6 Key strategic moves and developments

    • 10.2 Charles river

      • 10.2.1 Company overview

      • 10.2.2 Company snapshot

      • 10.2.3 Operating business segments

      • 10.2.4 Product portfolio

      • 10.2.5 Business performance

      • 10.2.6 Key strategic moves and developments

    • 10.3 Clini expert

      • 10.3.1 Company overview

      • 10.3.2 Company snapshot

      • 10.3.3 Operating business segments

      • 10.3.4 Product portfolio

      • 10.3.5 Business performance

      • 10.3.6 Key strategic moves and developments

    • 10.4 Emergo

      • 10.4.1 Company overview

      • 10.4.2 Company snapshot

      • 10.4.3 Operating business segments

      • 10.4.4 Product portfolio

      • 10.4.5 Business performance

      • 10.4.6 Key strategic moves and developments

    • 10.5 icbio cro

      • 10.5.1 Company overview

      • 10.5.2 Company snapshot

      • 10.5.3 Operating business segments

      • 10.5.4 Product portfolio

      • 10.5.5 Business performance

      • 10.5.6 Key strategic moves and developments

    • 10.6 icon plc

      • 10.6.1 Company overview

      • 10.6.2 Company snapshot

      • 10.6.3 Operating business segments

      • 10.6.4 Product portfolio

      • 10.6.5 Business performance

      • 10.6.6 Key strategic moves and developments

    • 10.7 IQVIA Holdings Inc.

      • 10.7.1 Company overview

      • 10.7.2 Company snapshot

      • 10.7.3 Operating business segments

      • 10.7.4 Product portfolio

      • 10.7.5 Business performance

      • 10.7.6 Key strategic moves and developments

    • 10.8 NKG

      • 10.8.1 Company overview

      • 10.8.2 Company snapshot

      • 10.8.3 Operating business segments

      • 10.8.4 Product portfolio

      • 10.8.5 Business performance

      • 10.8.6 Key strategic moves and developments

    • 10.9 parexel

      • 10.9.1 Company overview

      • 10.9.2 Company snapshot

      • 10.9.3 Operating business segments

      • 10.9.4 Product portfolio

      • 10.9.5 Business performance

      • 10.9.6 Key strategic moves and developments

    • 10.10 Pepgra

      • 10.10.1 Company overview

      • 10.10.2 Company snapshot

      • 10.10.3 Operating business segments

      • 10.10.4 Product portfolio

      • 10.10.5 Business performance

      • 10.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 3. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR REGULATORY CONSULTING /STRATEGIC SERVICES BY COUNTRY, 2021-2031,($MILLION)
    TABLE 1. GLOBAL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 2. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR REGULATORY CONSULTING /STRATEGIC SERVICES, BY REGION , 2021-2031,($MILLION)
    TABLE 4. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR REGULATORY WRITING AND PUBLISHING, BY REGION , 2021-2031,($MILLION)
    TABLE 5. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR REGULATORY WRITING AND PUBLISHING BY COUNTRY, 2021-2031,($MILLION)
    TABLE 6. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR LEGAL REPRESENTATION, BY REGION , 2021-2031,($MILLION)
    TABLE 7. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR LEGAL REPRESENTATION BY COUNTRY, 2021-2031,($MILLION)
    TABLE 8. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR PRODUCT REGISTRATION AND CLINICAL TRIALS, BY REGION , 2021-2031,($MILLION)
    TABLE 9. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR PRODUCT REGISTRATION AND CLINICAL TRIALS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 10. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
    TABLE 11. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 12. GLOBAL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 13. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR IN-HOUSE, BY REGION , 2021-2031,($MILLION)
    TABLE 14. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR IN-HOUSE BY COUNTRY, 2021-2031,($MILLION)
    TABLE 15. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR OUT SOURCING, BY REGION , 2021-2031,($MILLION)
    TABLE 23. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR INFECTIOUS DISEASES, BY REGION , 2021-2031,($MILLION)
    TABLE 24. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR INFECTIOUS DISEASES BY COUNTRY, 2021-2031,($MILLION)
    TABLE 25. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR ONCOLOGY AND HEMATOLOGY, BY REGION , 2021-2031,($MILLION)
    TABLE 16. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR OUT SOURCING BY COUNTRY, 2021-2031,($MILLION)
    TABLE 17. GLOBAL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 18. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR DIAGNOSTIC, BY REGION , 2021-2031,($MILLION)
    TABLE 19. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR DIAGNOSTIC BY COUNTRY, 2021-2031,($MILLION)
    TABLE 20. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR THERAPEUTICS, BY REGION , 2021-2031,($MILLION)
    TABLE 21. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR THERAPEUTICS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 22. GLOBAL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 26. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR ONCOLOGY AND HEMATOLOGY BY COUNTRY, 2021-2031,($MILLION)
    TABLE 27. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR GYNAECOLOGY AND OBSTETRICS, BY REGION , 2021-2031,($MILLION)
    TABLE 28. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR GYNAECOLOGY AND OBSTETRICS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 29. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR MUSCUSLOSKELETAL DISORDERS, BY REGION , 2021-2031,($MILLION)
    TABLE 30. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR MUSCUSLOSKELETAL DISORDERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 31. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR RESPIRATORY, BY REGION , 2021-2031,($MILLION)
    TABLE 32. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR RESPIRATORY BY COUNTRY, 2021-2031,($MILLION)
    TABLE 33. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR CARDIOVASCULAR, BY REGION , 2021-2031,($MILLION)
    TABLE 34. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR CARDIOVASCULAR BY COUNTRY, 2021-2031,($MILLION)
    TABLE 35. MEDICAL DEVICE REGULATORY AFFAIRS MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
    TABLE 36. MEDICAL DEVICE REGULATORY AFFAIRS MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 37. MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY REGION, 2021-2031,($MILLION)
    TABLE 38. NORTH AMERICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 39. NORTH AMERICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 40. NORTH AMERICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 41. NORTH AMERICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 42. NORTH AMERICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 43. U.S. MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 44. U.S. MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 45. U.S. MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 46. U.S. MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 47. CANADA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 48. CANADA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 49. CANADA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 50. CANADA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 51. MEXICO MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 52. MEXICO MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 65. FRANCE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 66. FRANCE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 67. FRANCE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 68. UNITED KINGDOM MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 69. UNITED KINGDOM MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 53. MEXICO MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 54. MEXICO MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 55. EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 56. EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 57. EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 58. EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 59. EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 60. GERMANY MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 61. GERMANY MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 62. GERMANY MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 63. GERMANY MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 64. FRANCE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 70. UNITED KINGDOM MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 71. UNITED KINGDOM MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 72. ITALY MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 73. ITALY MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 74. ITALY MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 75. ITALY MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 76. SPAIN MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 77. SPAIN MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 78. SPAIN MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 79. SPAIN MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 80. REST OF EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 81. REST OF EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 82. REST OF EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 83. REST OF EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 84. ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 85. ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 86. ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 87. ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 88. ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 89. JAPAN MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 90. JAPAN MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 91. JAPAN MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 92. JAPAN MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 93. CHINA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 95. CHINA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 96. CHINA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 97. INDIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 98. INDIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 99. INDIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 100. INDIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 101. SOUTH KOREA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 102. SOUTH KOREA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 94. CHINA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 103. SOUTH KOREA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 104. SOUTH KOREA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 105. MALAYSIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 106. MALAYSIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 107. MALAYSIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 108. MALAYSIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 109. REST OF ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 124. ISRAEL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 125. ISRAEL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 126. SAUDI ARABIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 127. SAUDI ARABIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 110. REST OF ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 111. REST OF ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 112. REST OF ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 113. LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 114. LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 115. LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 116. LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 117. LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 118. BRAZIL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 119. BRAZIL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 120. BRAZIL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 121. BRAZIL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 122. ISRAEL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 123. ISRAEL MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 128. SAUDI ARABIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 129. SAUDI ARABIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 130. SOUTH AFRICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 131. SOUTH AFRICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 132. SOUTH AFRICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 133. SOUTH AFRICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 134. REST OF LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICES, 2021-2031,($MILLION)
    TABLE 135. REST OF LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDER, 2021-2031,($MILLION)
    TABLE 136. REST OF LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY TYPES, 2021-2031,($MILLION)
    TABLE 137. REST OF LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET, BY INDICATION, 2021-2031,($MILLION)
    TABLE 138.AMERISOURCE BERGEN: COMPANY SNAPSHOT
    TABLE 139.AMERISOURCE BERGEN: OPERATING SEGMENTS
    TABLE 140.AMERISOURCE BERGEN: PRODUCT PORTFOLIO
    TABLE 141.AMERISOURCE BERGEN: NET SALES,
    TABLE 142.AMERISOURCE BERGEN: KEY STRATERGIES
    TABLE 143.CHARLES RIVER: COMPANY SNAPSHOT
    TABLE 144.CHARLES RIVER: OPERATING SEGMENTS
    TABLE 145.CHARLES RIVER: PRODUCT PORTFOLIO
    TABLE 146.CHARLES RIVER: NET SALES,
    TABLE 147.CHARLES RIVER: KEY STRATERGIES
    TABLE 148.CLINI EXPERT: COMPANY SNAPSHOT
    TABLE 149.CLINI EXPERT: OPERATING SEGMENTS
    TABLE 150.CLINI EXPERT: PRODUCT PORTFOLIO
    TABLE 151.CLINI EXPERT: NET SALES,
    TABLE 152.CLINI EXPERT: KEY STRATERGIES
    TABLE 153.EMERGO: COMPANY SNAPSHOT
    TABLE 154.EMERGO: OPERATING SEGMENTS
    TABLE 155.EMERGO: PRODUCT PORTFOLIO
    TABLE 156.EMERGO: NET SALES,
    TABLE 157.EMERGO: KEY STRATERGIES
    TABLE 158.ICBIO CRO: COMPANY SNAPSHOT
    TABLE 159.ICBIO CRO: OPERATING SEGMENTS
    TABLE 160.ICBIO CRO: PRODUCT PORTFOLIO
    TABLE 161.ICBIO CRO: NET SALES,
    TABLE 162.ICBIO CRO: KEY STRATERGIES
    TABLE 163.ICON PLC: COMPANY SNAPSHOT
    TABLE 164.ICON PLC: OPERATING SEGMENTS
    TABLE 165.ICON PLC: PRODUCT PORTFOLIO
    TABLE 166.ICON PLC: NET SALES,
    TABLE 167.ICON PLC: KEY STRATERGIES
    TABLE 168.IQVIA HOLDINGS INC.: COMPANY SNAPSHOT
    TABLE 169.IQVIA HOLDINGS INC.: OPERATING SEGMENTS
    TABLE 170.IQVIA HOLDINGS INC.: PRODUCT PORTFOLIO
    TABLE 171.IQVIA HOLDINGS INC.: NET SALES,
    TABLE 172.IQVIA HOLDINGS INC.: KEY STRATERGIES
    TABLE 173.NKG: COMPANY SNAPSHOT
    TABLE 174.NKG: OPERATING SEGMENTS
    TABLE 175.NKG: PRODUCT PORTFOLIO
    TABLE 176.NKG: NET SALES,
    TABLE 177.NKG: KEY STRATERGIES
    TABLE 178.PAREXEL: COMPANY SNAPSHOT
    TABLE 179.PAREXEL: OPERATING SEGMENTS
    TABLE 180.PAREXEL: PRODUCT PORTFOLIO
    TABLE 181.PAREXEL: NET SALES,
    TABLE 182.PAREXEL: KEY STRATERGIES
    TABLE 183.PEPGRA: COMPANY SNAPSHOT
    TABLE 184.PEPGRA: OPERATING SEGMENTS
    TABLE 185.PEPGRA: PRODUCT PORTFOLIO
    TABLE 186.PEPGRA: NET SALES,
    TABLE 187.PEPGRA: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.MEDICAL DEVICE REGULATORY AFFAIRS MARKET SEGMENTATION
    FIGURE 2.MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031
    FIGURE 3.MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.MEDICAL DEVICE REGULATORY AFFAIRS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.MEDICAL DEVICE REGULATORY AFFAIRS MARKET,BY SERVICES,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF REGULATORY CONSULTING /STRATEGIC SERVICES MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF REGULATORY WRITING AND PUBLISHING MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF LEGAL REPRESENTATION MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PRODUCT REGISTRATION AND CLINICAL TRIALS MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 18.MEDICAL DEVICE REGULATORY AFFAIRS MARKET,BY SERVICE PROVIDER,2021(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF IN-HOUSE MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OUT SOURCING MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 21.MEDICAL DEVICE REGULATORY AFFAIRS MARKET,BY TYPES,2021(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 23.COMPARATIVE SHARE ANALYSIS OF THERAPEUTICS MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 24.MEDICAL DEVICE REGULATORY AFFAIRS MARKET,BY INDICATION,2021(%)
    FIGURE 25.COMPARATIVE SHARE ANALYSIS OF INFECTIOUS DISEASES MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 26.COMPARATIVE SHARE ANALYSIS OF ONCOLOGY AND HEMATOLOGY MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 27.COMPARATIVE SHARE ANALYSIS OF GYNAECOLOGY AND OBSTETRICS MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 28.COMPARATIVE SHARE ANALYSIS OF MUSCUSLOSKELETAL DISORDERS MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 29.COMPARATIVE SHARE ANALYSIS OF RESPIRATORY MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 30.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 31.COMPARATIVE SHARE ANALYSIS OF OTHERS MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031(%)
    FIGURE 32.MEDICAL DEVICE REGULATORY AFFAIRS MARKET BY REGION,2021
    FIGURE 33.U.S. MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 34.CANADA MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 35.MEXICO MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 36.GERMANY MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 37.FRANCE MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 38.UNITED KINGDOM MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 39.ITALY MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 40.SPAIN MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 41.REST OF EUROPE MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 42.JAPAN MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 43.CHINA MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 44.INDIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 45.SOUTH KOREA MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 46.MALAYSIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 47.REST OF ASIA-PACIFIC MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 48.BRAZIL MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 49.ISRAEL MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 50.SAUDI ARABIA MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 51.SOUTH AFRICA MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 52.REST OF LAMEA MEDICAL DEVICE REGULATORY AFFAIRS MARKET,2021-2031($MILLION)
    FIGURE 53. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 54. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 55. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 56.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 57.COMPETITIVE DASHBOARD
    FIGURE 58.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 59.AMERISOURCE BERGEN.: NET SALES ,($MILLION)
    FIGURE 60.CHARLES RIVER.: NET SALES ,($MILLION)
    FIGURE 61.CLINI EXPERT.: NET SALES ,($MILLION)
    FIGURE 62.EMERGO.: NET SALES ,($MILLION)
    FIGURE 63.ICBIO CRO.: NET SALES ,($MILLION)
    FIGURE 64.ICON PLC.: NET SALES ,($MILLION)
    FIGURE 65.IQVIA HOLDINGS INC..: NET SALES ,($MILLION)
    FIGURE 66.NKG.: NET SALES ,($MILLION)
    FIGURE 67.PAREXEL.: NET SALES ,($MILLION)
    FIGURE 68.PEPGRA.: NET SALES ,($MILLION)

 
 

In accordance to several interviews conducted, the medical device regulatory affairs market is expected to witness a significant growth in the future, owing to benefits of regulatory services such as maintaining a smart quality system, including design controls to meet FDA, EU, and ISO 13485 requirements, among other qualifications and navigate the regulatory and development landscape while sticking to budgets and timelines.
According to perspectives of CXOs, the global medical device regulatory affairs market is expected to witness a steady growth in the future. The global medical device regulatory affairs market is progressing well as demand for faster approval processes grows. The need for the global medical device regulatory affairs market is being boosted by the rise of developing industries such as clinical research organization and pharmaceuticals. 
However, factors such as several additional regulatory difficulties, including medical device and in vitro diagnostic device regulation, as well as regulatory cybersecurity monitoring are complicating, these are expected to hamper growth of the market during the forecast period. On the contrary, rise in technological advancements and increase in government initiatives for medical device regulations are expected to drive growth of the global medical device regulatory affairs market.
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The global Medical Device Regulatory Affairs Market was valued at $6,969.7 million in 2021, and is projected to reach $12,247.7 million by 2031, registering a CAGR of 5.8% from 2022 to 2031.

A. North America was the largest shareholder in the medical device regulatory affairs market in 2021. Increase in geriatric population, R&D investments, and supportive government initiatives directed toward use of advanced medical devices for chronic diseases are the major factors that drive growth of the medical device regulatory affairs market.

A. Few trends such as the increase in R&D in developing medical devices especially diagnostic medical devices

A. Amerisource Bergen, Charles River, Icon Plc and Iqvia are few players to hold major share in the market

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Medical Device Regulatory Affairs Market

Start reading instantly.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (May 2023 - May 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers